Desmopressin
Desmopressin is a synthetic analogue of vasopressin, an antidiuretic hormone, used to manage conditions such as central diabetes insipidus, primary nocturnal enuresis, and nocturia in selected patients. It works by activating vasopressin V2 receptors in the kidneys, increasing water reabsorption and reducing urine production. Depending on the formulation and indication, desmopressin is available as oral tablets, nasal formulations, and injections. Certain formulations are also used to help control bleeding in selected patients with mild haemophilia A or von Willebrand disease. Common adverse effects include headache, nausea, and abdominal discomfort. Careful fluid management and medical monitoring are essential because desmopressin can cause water retention and potentially serious hyponatraemia (low blood sodium).
Desmopressin was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:
is okay
The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.
Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Desmopressin, subject to confirmation of its current regulatory status and eligibility for import into India.
The export of Desmopressin from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.
Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Desmopressin, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.
If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
All Trademarks and Brands that appear on the website belong to their respective owners. Primeera Healthcare does not lay any claim on them; we only provide information.
